B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
20
07
2022
accepted:
05
02
2023
entrez:
8
3
2023
pubmed:
9
3
2023
medline:
11
3
2023
Statut:
epublish
Résumé
The current study reveals that in chronic TB, the B cell-deficient μMT strain, relative to wild-type (WT) C57BL/6 mice, displays in the lungs lower levels of inflammation that are associated with decreased CD4+ T cell proliferation, diminished Th1 response, and enhanced levels of interleukin (IL)-10. The latter result raises the possibility that B cells may restrict lung expression of IL-10 in chronic TB. These observations are recapitulated in WT mice depleted for B cells using anti-CD20 antibodies. IL-10 receptor (IL-10R) blockade reverses the phenotypes of decreased inflammation and attenuated CD4+ T cell responses in B cell-depleted mice. Together, these results suggest that in chronic murine TB, B cells, by virtue of their capacity to restrict expression of the anti-inflammatory and immunosuppressive IL-10 in the lungs, promote the development of a robust protective Th1 response, thereby optimizing anti-TB immunity. This vigorous Th1 immunity and restricted IL-10 expression may, however, allow the development of inflammation to a level that can be detrimental to the host. Indeed, decreased lung inflammation observed in chronically infected B cell-deficient mice, which exhibit augmented lung IL-10 levels, is associated with a survival advantage relative to WT animals. Collectively, the results reveal that in chronic murine TB, B cells play a role in modulating the protective Th1 immunity and the anti-inflammatory IL-10 response, which results in augmentation of lung inflammation that can be host-detrimental. Intriguingly, in tuberculous human lungs, conspicuous B cell aggregates are present in close proximity to tissue-damaging lesions manifesting necrosis and cavitation, suggesting the possibility that in human TB, B cells may contribute to the development of exacerbated pathology that is known to promote transmission. Since transmission is a major hindrance to TB control, investigating into whether B cells can shape the development of severe pulmonic pathological responses in tuberculous individuals is warranted.
Identifiants
pubmed: 36888692
doi: 10.1371/journal.ppat.1011187
pii: PPATHOGENS-D-22-01271
pmc: PMC9994760
doi:
Substances chimiques
Interleukin-10
130068-27-8
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1011187Subventions
Organisme : NIAID NIH HHS
ID : K23 AI137183
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL071241
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI050732
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI094745
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI139297
Pays : United States
Informations de copyright
Copyright: © 2023 Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Cell Microbiol. 2006 Feb;8(2):218-32
pubmed: 16441433
Cell. 2012 Feb 3;148(3):434-46
pubmed: 22304914
Mucosal Immunol. 2011 May;4(3):261-70
pubmed: 21451501
Mucosal Immunol. 2011 May;4(3):288-93
pubmed: 21451503
PLoS Pathog. 2019 Mar 6;15(3):e1007613
pubmed: 30840702
Clin Infect Dis. 2004 Jan 1;38(1):e10-4
pubmed: 14679469
Tuberculosis (Edinb). 2011 Nov;91(6):497-509
pubmed: 21733755
J Immunol. 2000 Jun 15;164(12):6417-25
pubmed: 10843697
Immunol Cell Biol. 2007 Feb-Mar;85(2):103-11
pubmed: 17213830
Am J Respir Crit Care Med. 2018 Mar 15;197(6):801-813
pubmed: 29161093
N Engl J Med. 1996 Dec 26;335(26):1956-61
pubmed: 8960475
Nat Rev Immunol. 2015 Jul;15(7):441-51
pubmed: 26065586
J Clin Invest. 2021 Feb 1;131(3):
pubmed: 33301427
Nat Rev Immunol. 2018 Sep;18(9):575-589
pubmed: 29895826
J Immunol. 1999 Jun 1;162(11):6740-6
pubmed: 10352293
J Bacteriol. 2008 Jun;190(12):4360-6
pubmed: 18408028
J Immunol. 2004 Jun 15;172(12):7603-9
pubmed: 15187140
Cell Immunol. 2005 Dec;238(2):67-75
pubmed: 16574086
mBio. 2015 Feb 17;6(1):e02537-14
pubmed: 25691598
Annu Rev Immunol. 2013;31:475-527
pubmed: 23516984
Infect Disord Drug Targets. 2012 Jun;12(3):213-21
pubmed: 22394173
Exp Parasitol. 2005 Oct;111(2):97-104
pubmed: 16087175
Eur Respir Rev. 2018 Feb 28;27(147):
pubmed: 29491034
Cell Rep. 2017 Mar 28;18(13):3091-3104
pubmed: 28355562
Infect Immun. 2011 Nov;79(11):4668-73
pubmed: 21896775
Curr Dir Autoimmun. 2005;8:25-54
pubmed: 15564716
Helicobacter. 2005 Oct;10(5):407-15
pubmed: 16181351
Semin Immunol. 2014 Dec;26(6):588-600
pubmed: 25458990
Nat Rev Immunol. 2019 Apr;19(4):205-217
pubmed: 30770905
Nat Commun. 2022 Feb 16;13(1):884
pubmed: 35173157
Nat Rev Immunol. 2010 Apr;10(4):236-47
pubmed: 20224569
PLoS Pathog. 2009 Aug;5(8):e1000545
pubmed: 19680450
Nat Immunol. 2000 Dec;1(6):475-82
pubmed: 11101868
Curr Opin Immunol. 2015 Jun;34:22-7
pubmed: 25597442
Nat Immunol. 2022 Feb;23(2):318-329
pubmed: 35058616
Immunol Rev. 2008 Jun;223:114-31
pubmed: 18613832
J Immunol. 2014 Apr 1;192(7):2965-9
pubmed: 24591367
Nat Rev Immunol. 2014 Jul;14(7):447-62
pubmed: 24948366
Nat Genet. 1999 Apr;21(4):370-8
pubmed: 10192386
Nat Rev Immunol. 2017 Nov;17(11):691-702
pubmed: 28736436
Curr Opin Immunol. 2007 Feb;19(1):93-8
pubmed: 17140785
Annu Rev Immunol. 1990;8:773-93
pubmed: 2188679
J Immunol. 1996 Jul 15;157(2):798-805
pubmed: 8752931
J Autoimmun. 2014 Dec;55:10-23
pubmed: 24794622
J Exp Med. 2018 Jul 2;215(7):1823-1838
pubmed: 29773644
J Exp Med. 2013 Dec 16;210(13):2921-37
pubmed: 24323356
Nat Rev Immunol. 2006 Mar;6(3):205-17
pubmed: 16498451
J Exp Med. 1993 Dec 1;178(6):2249-54
pubmed: 7504064
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5636-44
pubmed: 27601645
Eur J Immunol. 2010 Aug;40(8):2200-10
pubmed: 20518032
J Clin Invest. 1997 Dec 1;100(11):2658-64
pubmed: 9389728
Infect Immun. 1999 Sep;67(9):4531-8
pubmed: 10456896
Curr Opin Immunol. 2008 Jun;20(3):332-8
pubmed: 18417336
Front Immunol. 2021 Jun 15;12:611673
pubmed: 34220793
J Exp Med. 1993 Dec 1;178(6):2243-7
pubmed: 8245795
Annu Rev Immunol. 2001;19:683-765
pubmed: 11244051
Annu Rev Immunol. 2001;19:93-129
pubmed: 11244032
J Immunol. 2009 Dec 15;183(12):8004-14
pubmed: 19933855
Infect Immun. 1999 Sep;67(9):4435-42
pubmed: 10456884
Am J Respir Crit Care Med. 2021 Sep 1;204(5):583-595
pubmed: 34015247
Nature. 1991 Apr 4;350(6317):423-6
pubmed: 1901381
PLoS Pathog. 2016 May 31;12(5):e1005667
pubmed: 27244558
J Pathol. 2007 Jul;212(3):295-305
pubmed: 17534845
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
PLoS Pathog. 2013;9(7):e1003472
pubmed: 23853593
Annu Rev Immunol. 2011;29:71-109
pubmed: 21166540
J Immunol. 2013 Mar 15;190(6):2778-90
pubmed: 23396944
Front Immunol. 2021 Apr 19;12:660916
pubmed: 33953722
Microbes Infect. 2006 Apr;8(4):1141-50
pubmed: 16520078
J Infect Dis. 2005 Oct 1;192(7):1201-9
pubmed: 16136463
J Immunol. 2008 Oct 15;181(8):5545-50
pubmed: 18832712
Sci Transl Med. 2013 Nov 27;5(213):213sr6
pubmed: 24285487
Nat Immunol. 2013 May;14(5):419-21
pubmed: 23598388
J Immunol. 2005 Jul 1;175(1):15-20
pubmed: 15972625
Immunology. 2005 Jun;115(2):246-52
pubmed: 15885131
Cell. 2013 Apr 25;153(3):521-34
pubmed: 23582643
Viral Immunol. 2006 Summer;19(2):147-55
pubmed: 16817757
J Immunol. 2007 Jun 1;178(11):7222-34
pubmed: 17513771
J Clin Invest. 2013 Feb;123(2):712-26
pubmed: 23281399
J Exp Med. 2018 May 7;215(5):1273-1285
pubmed: 29666166
Vet Immunol Immunopathol. 2007 Oct 15;119(3-4):204-13
pubmed: 17628695
J Exp Med. 2015 May 4;212(5):715-28
pubmed: 25918344
Annu Rev Immunol. 1993;11:571-611
pubmed: 8476573
Nat Immunol. 2013 May;14(5):514-22
pubmed: 23563688
J Immunol. 2011 Jul 1;187(1):372-81
pubmed: 21602490
J Pathol. 2004 Oct;204(2):217-28
pubmed: 15376257